NMDAR-Dependent Maturation of PV Interneuron GABA Release Me
2026-06-22
This study uncovers how NMDA receptor (NMDAR) signaling in developing neocortical parvalbumin (PV) interneurons orchestrates the recruitment of Cav2.1 channels for synchronized GABA release. These findings clarify the cellular basis of inhibition deficits in schizophrenia models and highlight the specificity of NMDAR-Cav2.1 coupling for interneuron maturation and inhibitory circuit function.
IWR-1-endo: Mechanistic Insights and Assay Innovation in Wnt
2026-06-22
Explore the advanced mechanisms by which IWR-1-endo, a potent Wnt signaling inhibitor, drives innovation in colorectal cancer and regenerative biology research. This article uniquely integrates mechanistic depth with assay design insights, providing an authoritative resource for scientists seeking optimized applications.
VX-702: Precision p38α MAPK Inhibition and Dephosphorylation
2026-06-21
Explore how VX-702, a selective p38α MAPK inhibitor, uniquely modulates kinase dephosphorylation and cytokine suppression. This article provides advanced insights for inflammation and myocardial injury research, distinguishing itself with a focus on structural and conformational assay implications.
AR Heterogeneity Drives Divergent Prostate Cancer Therapy Re
2026-06-20
This study illuminates how androgen receptor (AR) expression heterogeneity in prostate cancer underlies distinct responses to castration and enzalutamide therapies. By dissecting AR+/hi and AR−/lo cell populations, the research uncovers critical molecular pathways and therapeutic vulnerabilities, with implications for overcoming resistance in advanced prostate cancer.
USP36–Snail1 Axis Drives Ribosome Biogenesis and Tumor Survi
2026-06-19
This study uncovers how USP36 stabilizes nucleolar Snail1 to promote ribosome biogenesis and enhance cancer cell survival under ribotoxic stress. The findings provide a mechanistic rationale for targeting the JNK–USP36–Snail1 pathway to overcome resistance in solid tumor therapies based on ribosome inhibition.
Balsalazide Disodium: Targeted 5-ASA Prodrug for Ulcerative
2026-06-19
The reference study systematically evaluates balsalazide disodium, a targeted prodrug of 5-aminosalicylic acid, for its efficacy and safety in the treatment of active ulcerative colitis. The findings highlight its unique colonic activation, rapid induction of remission, and favorable tolerability, informing both clinical and preclinical inflammation research.
Lysosomal β-Galactosidase Staining Kit: Precision in Senesce
2026-06-18
The Lysosomal β-Galactosidase Staining Kit offers artifact-free, polystyrene-compatible detection of lysosomal enzyme activity, crucial for controlling and validating senescence studies. Its optimized workflow and specificity enable reproducible, high-fidelity results in both basic and translational cancer research.
Cyclophosphamide Applications: Protocols, Innovations & Trou
2026-06-18
Cyclophosphamide's versatility as an alkylating chemotherapeutic agent makes it indispensable for cancer research, apoptosis induction, and immune modulation. Discover optimized workflows, advanced applications, and expert troubleshooting tips to maximize reproducibility and translational impact, leveraging APExBIO's high-purity Cyclophosphamide.
Repurposing FDA-Approved Drugs to Modulate DNA Repair in CRI
2026-06-17
This study systematically screens FDA-approved drugs to identify modulators of DNA double-strand break (DSB) repair pathways during CRISPR genome editing. The findings reveal actionable compounds that shift repair outcomes, inform synthetic lethality strategies, and have broad implications for gene therapy, cancer research, and drug repositioning screening.
NO-Releasing Tranexamic Acid Dressings for Rapid Trauma Hemo
2026-06-17
This study introduces a bi-layer wound dressing combining tranexamic acid, a nitric oxide donor, and propolis to achieve instant clot formation and strong antibacterial effects in traumatic injuries. The innovation demonstrates both enhanced hemostasis and infection control, offering a promising advancement for emergency wound care and antifibrinolytic agent research.
Applied PX-478 2HCl: Experimental Workflows in Hypoxia Resea
2026-06-16
PX-478 2HCl, a potent HIF-1α inhibitor, empowers researchers to dissect hypoxia-driven pathways from cancer biology to neurodevelopmental disorders. This guide translates recent breakthroughs, including ASD models, into actionable protocols and troubleshooting tactics for robust bench success.
2-(4,5,6,7-Tetrabromo) Small Molecule Inhibitor in Kinase Re
2026-06-16
Unlock precise control over protein kinase-driven phase separation using the CK2 and ERK8 inhibitor, a high-purity, DMSO-soluble small molecule tool. This guide delivers optimized experimental workflows, troubleshooting insights, and practical applications, empowering researchers to dissect complex enzyme interactions with confidence.
Plk1-Mediated Regulation of p31comet in Mitotic Checkpoint D
2026-06-15
This study reveals how Polo-like kinase 1 (Plk1) phosphorylates p31comet to regulate the disassembly of mitotic checkpoint complexes (MCC) and control mitotic progression. By defining a phosphorylation-dependent inhibition of p31comet, the findings clarify a key mechanism in chromosome segregation fidelity with implications for targeting mitotic regulators in cell cycle research.
HRP Rabbit Anti-Goat IgG (H+L) Antibody: Precision in Immuno
2026-06-15
Unlock unmatched sensitivity for immunodetection of goat primary antibodies using the HRP Rabbit Anti-Goat IgG (H+L) Antibody. This guide translates cutting-edge research into actionable protocols and troubleshooting strategies to elevate your ELISA, IHC, and western blot workflows.
Veratridine as a Precision Neurotoxin: Advanced Insights for
2026-06-14
Explore how Veratridine, a voltage-gated sodium channel opener, advances sodium channel dynamics and excitotoxicity research. This article uniquely dissects mechanistic and assay design implications, providing expert guidance for neuroscience and oncology workflows.
470 records 15/32 page Previous Next First page 上5页 1112131415 下5页 Last page